Brief: Toleranzia Q1 Loss After Financial Items Widens To SEK 2.1 Mln
May 6 (Reuters) - Toleranzia AB TOLE.ST :
* Q1 NET SALES 0 SEK (0 SEK)
* Q1 PROFIT/LOSS AFTER FINANCIAL ITEMS -2 071 922 SEK (-1
422 555
SEK)
* DURING Q1 OF YEAR, WE HAVE CONTINUED TO DRIVE TOLERANZIA
FORWARD
IN AN EFFICIENT AND SYSTEMATIC WAY, TAKING IMPORTANT STEPS
TOWARDS FIRST CLINICAL TRIAL OF OUR LEAD DRUG CANDIDATE TOL2 IN
MYASTHENIA GRAVIS
Source text for Eikon: ID:nMFN9cf3gf
Further company coverage: TOLE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Toleranzia AB
See all newsBrief: Swedish Companies Registration Office Permits Implementation of Flerie, Toleranzia's M&A
Brief: Toleranzia Q2 Net Income SEK -2.911 Million
Brief: Nasdaq Stockholm Approves Toleranzia’S Application For Delisting
Brief: Toleranzia Applies For Delisting Of Shares On Nasdaq
Brief: Toleranzia Approves Merger Plan Adopted By Boards Of Toleranzia, Flerie